2-Amino-5-nitrothiazoleCAS# 121-66-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 121-66-4 | SDF | Download SDF |
PubChem ID | 8486 | Appearance | Powder |
Formula | C3H3N3O2S | M.Wt | 145 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5-nitro-1,3-thiazol-2-amine | ||
SMILES | C1=C(SC(=N1)N)[N+](=O)[O-] | ||
Standard InChIKey | MIHADVKEHAFNPG-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C3H3N3O2S/c4-3-5-1-2(9-3)6(7)8/h1H,(H2,4,5) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
2-Amino-5-nitrothiazole Dilution Calculator
2-Amino-5-nitrothiazole Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 6.8966 mL | 34.4828 mL | 68.9655 mL | 137.931 mL | 172.4138 mL |
5 mM | 1.3793 mL | 6.8966 mL | 13.7931 mL | 27.5862 mL | 34.4828 mL |
10 mM | 0.6897 mL | 3.4483 mL | 6.8966 mL | 13.7931 mL | 17.2414 mL |
50 mM | 0.1379 mL | 0.6897 mL | 1.3793 mL | 2.7586 mL | 3.4483 mL |
100 mM | 0.069 mL | 0.3448 mL | 0.6897 mL | 1.3793 mL | 1.7241 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- N-Acetylsulfanilyl chloride
Catalog No.:BCC9084
CAS No.:121-60-8
- Benzethonium Chloride
Catalog No.:BCC4635
CAS No.:121-54-0
- (-)-Terreic acid
Catalog No.:BCC7051
CAS No.:121-40-4
- Vanillic acid
Catalog No.:BCN6105
CAS No.:121-34-6
- Vanillin
Catalog No.:BCN2605
CAS No.:121-33-5
- 3-Deazaneplanocin A (DZNep) hydrochloride
Catalog No.:BCC3604
CAS No.:120964-45-6
- FPL 64176
Catalog No.:BCC7050
CAS No.:120934-96-5
- Isoliquiritin apioside
Catalog No.:BCN2914
CAS No.:120926-46-7
- PF-03394197(Oclacitinib)
Catalog No.:BCC6474
CAS No.:1208319-26-9
- N6022
Catalog No.:BCC4127
CAS No.:1208315-24-5
- Ketone Ester
Catalog No.:BCC1677
CAS No.:1208313-97-6
- VU 0365114
Catalog No.:BCC6164
CAS No.:1208222-39-2
- Propyl gallate
Catalog No.:BCN8431
CAS No.:121-79-9
- 3'-Nitroacetophenone
Catalog No.:BCN2256
CAS No.:121-89-1
- ST 1936 oxalate
Catalog No.:BCC7919
CAS No.:1210-81-7
- N-Acetyl-5-Hydroxytryptamine
Catalog No.:BCC9080
CAS No.:1210-83-9
- JZL 195
Catalog No.:BCC7966
CAS No.:1210004-12-8
- Secretin (rat)
Catalog No.:BCC5848
CAS No.:121028-49-7
- Nelarabine
Catalog No.:BCC1072
CAS No.:121032-29-9
- IEM 1460
Catalog No.:BCC7135
CAS No.:121034-89-7
- PF-04971729
Catalog No.:BCC1852
CAS No.:1210344-57-2
- Abiesadine I
Catalog No.:BCN6104
CAS No.:1210347-50-4
- Melanotan II
Catalog No.:BCC7414
CAS No.:121062-08-6
- 3-O-trans-p-Coumaroyltormentic acid
Catalog No.:BCN4724
CAS No.:121064-78-6
2-Amino-5-nitrothiazole monoethanol solvate: triply-interwoven hydrogen-bonded sheets containing centrosymmetric R2 2(8) and RR10 10(38) rings.[Pubmed:14712035]
Acta Crystallogr C. 2004 Jan;60(Pt 1):o15-8. Epub 2003 Dec 6.
2-Amino-5-nitrothiazole crystallizes from solution in ethanol as a monosolvate, C(3)H(3)N(3)O(2)S.C(2)H(6)O, in which the thiazole component has a strongly polarized molecular-electronic structure. The thiazole molecules are linked into centrosymmetric dimers by paired N-H...N hydrogen bonds [H...N = 2.09 A, N.N = 2.960 (6) A and N-H...N = 169 degrees ], and these dimers are linked by the ethanol molecules, via a two-centred N-H...O hydrogen bond [H...O = 1.98 A, N...O = 2.838 (5) A and N-H...O = 164 degrees ] and a planar asymmetric three-centred O-H...(O)(2) hydrogen bond [H...O = 2.07 and 2.53 A, O...O = 2.900 (5) and 3.188 (5) A, O-H...O = 169 and 136 degrees, and O...H...O = 55 degrees ], into sheets built from alternating R(2)(2)(8) and R(10)(10)(38) rings. These sheets are triply interwoven.
On the capacity of nitroheterocyclic compounds to elicit an unusual axial asymmetry in cultured rat embryos.[Pubmed:3945955]
Toxicol Appl Pharmacol. 1986 Feb;82(2):307-15.
A series of nitroheterocyclic compounds with antimicrobial and radiosensitizing properties was tested for embryotoxicity in cultured Sprague-Dawley rat embryos, and their effects were compared with various other five-membered heterocycles. Nifuroxime, furazolidone, nitrofurazone, niridazole, 2-nitroimidazole, and ronidazole each elicited a striking malformation characterized by asymmetrical, right-sided hypoplasia when coincubated with embryos for 26 hr. Minimum concentrations required to elicit this unusual defect ranged from 0.01 mM with nifuroxime and furazolidone to 0.5 mM with ronidazole and were roughly correlated with single electron redox potentials; i.e., agents with relatively high redox potentials were generally more effective than those with low potentials. Nitrofurantoin failed to elicit this unusual malformation but exhibited an extremely steep dose-response curve for embryolethality. Metronidazole and 4-nitroimidazole, nitroheterocyclic agents with relatively low redox potentials, did not produce the asymmetric abnormality nor were they highly embryotoxic, even at concentrations up to 2 mM. 2-Amino-5-nitrothiazole and 4'-methylniridazole also failed to evoke the asymmetric malformation but produced significant embryotoxicity as manifested by decreased growth parameters and elicitation of other kinds of malformations. Heterocyclic compounds not bearing a nitro group (furosemide, 2-aminothiazole, and 2-aminoimidazole) failed to elicit axial asymmetry at concentrations up to 1.0 mM but produced other signs of embryotoxicity at the highest concentrations tested. The results suggest that the presence of a reducible nitro group is critical for generation of the unusual malformation and that the single-electron redox potential of the nitro group plays a dominant but not exclusive role in the capacity of these chemicals to evoke axial asymmetry in cultured rat embryos.